Skip to content

Oxyfit Pulse Oximeter

by Shenzhen Viatom Technology Co., Ltd.

510(k) K203812

Active European Union and United States

CE MDR CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK203812 Date8 Nov 2022ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
28 Dec 2020
FDA decision
8 Nov 2022 (Substantially Equivalent)
FDA review time
680 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K203812 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K203812 decided 8 Nov 2022 Active
  • EUDAMED Active· +1 more in the status table

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR, CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
DQA
Device class
Class II
Regulation
21 CFR Part 870.2700
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Oxyfit Pulse Oximeter is a non-invasive device classified as a pulse oximeter, designed to measure arterial oxygen saturation (SpO₂) and pulse rate in patients. It provides real-time monitoring of blood oxygen levels and heart rate, aiding in the assessment of respiratory and circulatory function during clinical evaluations or home use.

This device is supplied as a single-use or reusable (depending on model) and is intended for use in clinical settings, including hospitals, outpatient facilities, and home monitoring environments. It adheres to FDA 510(k) clearance under the traditional pathway, with regulatory compliance also meeting the Medical Device Directive (MDD) and Medical Device Regulation (MDR) standards. The device is available in standard configurations, with no specific size variations noted in the specifications.

Devices cleared under K203812

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K203812
UDI-DISize and differences
Viatom PO6 Oxyfit Pulse Oximeter
Shenzhen Viatom Technology Co., Ltd.
PO6 Oxyfit Pulse Oximeter06934440101994
Prescription: no
On the market
Viatom PO6 Oxyfit Pulse Oximeter
Shenzhen Viatom Technology Co., Ltd.
PO6 Oxyfit Pulse Oximeter06934440102311
Prescription: yes
On the market

Similar devices

Other devices filed under FDA product code DQA (Oximeter).

Other devices from Viatom Technology Co., Ltd.

See all devices from Viatom Technology Co., Ltd. →